Medtronic neuroscience president Brett Wall to depart; Kweli Thompson named successor

Medtronic plc

Brett Wall steps down as EVP & President, Neuroscience Portfolio; effective June 1, 2026.
Dr. Kweli Thompson moves from SVP & President, Cardiac Rhythm Management to succeed him.
Wall will remain an employee through September 1, 2026 to assist transition.
Severance consistent with Medtronic's executive severance practices per 2025 proxy.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Brett Wall

Executive Vice President and President, Neuroscience Portfolio

MDT · Medtronic plc

Effective: 2026-06-01
Successor: Kweli Thompson
Filed: May 18, 2026, 4:30 PM ET

Brett Wall will be departing from his position as Executive Vice President and President, Neuroscience Portfolio

Appointed

Kweli Thompson

Executive Vice President and President, Neuroscience Portfolio

MDT · Medtronic plc

Effective: 2026-06-01
Filed: May 18, 2026, 4:30 PM ET

Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will be assuming the role of Executive Vice President and President, Neuroscience Portfolio, effective June 1, 2026.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brett Wall departed as Executive Vice President and President, Neuroscience Portfolio at Medtronic plc.

Action: departing
Role: Executive Vice President and President, Neuroscience Portfolio

Exact text from the filing

Brett Wall will be departing from his position as Executive Vice President and President, Neuroscience Portfolio

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Kweli Thompson changed role as Executive Vice President and President, Neuroscience Portfolio at Medtronic plc.

Action: assuming the role
Role: Executive Vice President and President, Neuroscience Portfolio

Exact text from the filing

Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will be assuming the role of Executive Vice President and President, Neuroscience Portfolio, effective June 1, 2026.

View on SEC.gov

Medtronic plc filing history →

Source: SEC EDGAR

accession 0001628280-26-035959

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.